Toosendanin, a triterpenoid derivative, increases Ca2+ current in NG108-15 cells via L-type channels

Neuroscience Research

Volumn 49, Issue 2, 2004, Pages 197-203

  Li, Mu Feng ^a   Wu, Ying ^a   Wang, Zhong Feng ^a   Shi, Yu Liang ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Antibotulismic agent; Calcium channel; Facilitatory effect; L type; Toosendanin; Whole cell recording

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM CHANNEL T TYPE; CALCIUM ION; NIFEDIPINE; OMEGA CONOTOXIN MVIIC; TOOSENDANIN; TRITERPENOID; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; INCUBATION TIME; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL;

ANIMALS; BARIUM; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELL DIFFERENTIATION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; MEMBRANE POTENTIALS; MICE; NEUROBLASTOMA; PATCH-CLAMP TECHNIQUES;

EID: 2342640113     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2004.02.012     Document Type: Article

References (42)

1. A receptor-chloride channel complex. In: Narahashi, T. (Ed.), Methods in Neurosciences, Ion Channels of Excitable Cells. Academic Press, San Diego, pp. 148-156.
2. Atchison W.D. Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals. J. Pharmacol. Exp. Ther. 251:1989;672-678
3. 2+ channels. Trends Pharmacol Sci. 9:1988;257-261
4. Brown D.A., Docherty R.J., McFadzen I. Calcium channels in vertebrate neurons. Experiment on neuroblastoma hybrid model. Ann. New York Acad. Sci. 560:1989;358-372
5. Brown D.A., Higashida H. Voltage and calcium-activated potassium currents in mouse neuroblastoma × rat glioma hybrid cells. J. Physiol. (Lond.). 397:1988;149-165
6. 2+ current in neuroblastoma × glioma hybrid (NG108-15) cells, not the nifedipine-sensitive component. Pflügers Arch. 420:1992;486-492
7. Chang C.C., Hsie T.H., Chen S.F., Liang H.T. The structure of Chuanliansu. Acta Chem. Sin. 33:1975;35-47
8. Chen W.Y., Yin P.B., Ye W.L., Shi Y.L. Toosendanin-induced change of dopamine level detected by microdialysis in vivo at rat striatum. Chin. Sci. Bull. 44:1999;502-506
9. Docherty, R.J., Robbins, J., Brown, D.A., 1992. NG108-15 neuroblastoma × glioma hybrid cell line as a model neuronal system. In: Chad, J., Wheal, H. (Eds.), Cellular Neurobiology, A Practical Approach. Oxford University Press, Oxford, pp. 75-95.
10. Furuya K., Furuya S., Yamagishi S. Developmental time courses of Na and Ca spikes in neuroblastoma × glioma hybrid cells. Dev. Brain Res. 11:1983;229-234
11. 2+ channels in guinea-pig ventricular myocytes through independent mechanisms. J. Physiol. 444:1991;257-268
12. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:1981;85-100
13. Hanson P.I., Heuser J.E., John R. Neurotransmitter release-four years of SNARE complexes. Curr. Opin. Neurobiol. 7:1997;310-315
14. Hu Q., Huang F.S., Shi Y.L. Inhibition of toosendanin on the delayed rectifier potassium current in neuroblastoma × glioma NG108-15 cells. Brain Res. 751:1997;47-53
15. Hu Q., Shi Y.L. Characterization of an inward-rectifying potassium current in NG108-15 neuroblastoma × glioma cells. Pflügers Arch. 433:1997;617-625
16. Kasai H., Neher E. Dihydropyridine-sensitive and ω-conotoxin- sensitive calcium channels in a mammalian neuroblastoma × glioma cell line. J. Physiol. (Lond.). 448:1992;161-188
17. Katz E., Ferro P.A., Weisz G., Uchitel O.D. Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction. J. Physiol. (Lond.). 497:1996;687-697
18. Li P.Z., Zhou J., Miao W.Y., Ding F.H., Meng J.Y., Jia G.R., Li J.F., Ye H.J., He X.Y., Chen M.Y., Huang Z.M. Therapeutic effect of toosendanin on animal botulism. Chin. Tradit. Herb. Drugs. 13:1982;28-30
19. Lindau M., Neher E. Patch-clamp techniques for time-resolved capacitance measurements in single cells. Pflügers Arch. 411:1988;137-146
20. Lukyanetz E.A. Diversity and properties of calcium channel types in NG108-15 hybrid cells. Neuroscience. 87:1998;265-274
21. Markwardt F., Nilius B. Modulation of calcium channel currents in guinea-pig single ventricular heart cells by the dihydropyridine BAY K 8644. J. Physiol. 399:1988;559-575
22. Pancrazio J.J., Viglione M.P., Kim Y.I. Effects of Bay K 8644 on spontaneous and evoked transmitter release at the mouse neuromuscular junction. Neuroscience. 30:1989;215-221
23. Santafe M.M., Urbano F.J., Lanuza M.A., Uchitel O.D. Multiple types of calcium channels mediate transmitter release during functional recovery of botulinum toxin type A-poisoned mouse motor nerve terminals. Neuroscience. 95:2000;227-234
24. Schiavo G., Rossetto O., Montecucco C. Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release. Semi. Cell Biol. 5:1994;221-229
25. 3H -Toosendanin in rat cerebral cortex homogenate Acta Physiol. Sin. 46:1994;546-552
26. Shi Y.L., Chen W.Y. Effect of toosendanin on acetylcholine level of rat brain, a microdialysis study. Brain Res. 850:1999;173-178
27. 2+ conductance increase in neuroblastoma × glioma hybrid cells. Chin. Sci. Bull. 38:1993;1489-1493
28. Shi Y.L., Wang W.P., Xu K. Electrophysiological analysis on the presynaptic blocking effects of toosendanin on neuromuscular transmission. Acta Physiol. Sin. 33:1981a;259-265
29. Shi Y.L., Wang W.P., Yan S.C., Xu K. Effects of calcium ion and nerve impulses on changes in miniature end-plate potential frequency produced by toosendanin. Acta Physiol. Sin. 34:1982;304-309
30. Shi Y.L., Wei N.S., Yang Y.Q., Wang Z.X. Toosendanin - a presynaptic neuromuscular blocking agent. Acta Physiol. Sin. 32:1980;293-297
31. Shi Y.L., Xu K. Antibotulismic effect of toosendanin. Chin. Sci. Bull. 28:1983a;885-887
32. Shi Y.L., Xu K. Anti-botulismic effect of toosendanin and its facilitatory action on miniature end-plate potentials. Jpn. J. Physiol. 33:1983b;677-680
33. 2+ on onset of toosendanin paralysis of isolated neuromuscular preparations. Acta Physiol. Sin. 33:1981b;141-146
34. Shu G.X., Liang X.T. A correction of the structure of Chuanliansu. Acta Chim. Sin. 38:1980;196-198
35. Wang Y.B., Wen Y.X. A comprehensive report on clinical ascaris anthelmintic therapeutic effect of Toosendanin pills. J. Tradit. Chin. Med. 262:1959;46-49
36. + channels in hippocampal neurons by toosendanin. Neuroscience. 104:2001a;41-47
37. Wang Z.F., Shi Y.L. Toosendanin-induced inhibition of small-conductance calcium-activated potassium channels in CA1 pyramidal neurons of rat hippocampus. Neurosci. Lett. 303:2001b;13-16
38. Wang Z.F., Shi Y.L. Modulation of inward rectifier potassium channel by toosendanin, a presynaptic blocker. Neurosci. Res. 40:2001c;211-215
39. Xu Y.F., Shi Y.L. Action of Toosendanin on the membrane current of mouse motor nerve terminals. Brain Res. 631:1993;46-50
40. 2+ channels. Acta Pharmacol. Sin., in press.
41. +-evoked glutamate release from rat synaptosomes by toosendanin. 6th Chin. Congr. Biol. Toxin, Changsha, P39.
42. Zhou J.Y., Wang Z.F., Ren X.M., Tang M.Z., Shi Y.L. Antagonism of botulism toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin. FEBS Lett. 555:2003;375-379